Lv1
10 积分 2023-05-30 加入
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients
12天前
已完结
Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine
13天前
已完结
Controversies in metastatic hormone‐sensitive prostate cancer
13天前
已完结
Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer
13天前
已完结
ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients
13天前
已完结
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trial
1个月前
已完结
Patient‐reported outcomes of a phase II neoadjuvant apalutamide (ARN‐509) and radical prostatectomy in treatment of intermediate‐ to high‐risk prostate cancer (NEAR) trial
1个月前
已完结
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer
1个月前
已完结
[Current research progress and prospects in neoadjuvant therapy for prostate cancer]
1个月前
已完结
局部晚期前列腺癌新辅助治疗的研究现状和展望
1个月前
已完结
皖公网安备34019202002308
